Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 7 studies | 32% ± 5% | |
| epithelial cell | 6 studies | 42% ± 17% | |
| keratinocyte | 5 studies | 48% ± 27% | |
| squamous epithelial cell | 3 studies | 36% ± 4% | |
| luminal hormone-sensing cell of mammary gland | 3 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of LYPD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 39% | 25796.67 | 560 / 1445 | 69% | 305.48 | 127 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 618.99 | 43 / 45 |
| bladder | 29% | 1417.52 | 6 / 21 | 66% | 224.55 | 331 / 504 |
| breast | 7% | 244.34 | 31 / 459 | 87% | 77.08 | 974 / 1118 |
| skin | 72% | 33149.87 | 1301 / 1809 | 12% | 41.41 | 57 / 472 |
| prostate | 7% | 309.49 | 17 / 245 | 70% | 21.75 | 351 / 502 |
| uterus | 1% | 681.27 | 2 / 170 | 70% | 394.73 | 322 / 459 |
| lung | 0% | 0 | 0 / 578 | 51% | 103.12 | 590 / 1155 |
| pancreas | 0% | 0 | 0 / 328 | 30% | 38.03 | 53 / 178 |
| ovary | 4% | 168.06 | 8 / 180 | 14% | 6.83 | 62 / 430 |
| intestine | 0% | 0 | 0 / 966 | 10% | 19.13 | 53 / 527 |
| stomach | 1% | 74.06 | 5 / 359 | 8% | 5.36 | 22 / 286 |
| thymus | 0% | 0 | 0 / 653 | 4% | 2.66 | 22 / 605 |
| adrenal gland | 1% | 27.15 | 2 / 258 | 1% | 0.28 | 2 / 230 |
| kidney | 0% | 0 | 0 / 89 | 1% | 1.77 | 8 / 901 |
| adipose | 1% | 39.05 | 9 / 1204 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.18 | 2 / 406 |
| muscle | 0% | 14.49 | 2 / 803 | 0% | 0 | 0 / 0 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0.03 | 1 / 705 |
| blood vessel | 0% | 18.22 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0034392 | Biological process | negative regulation of smooth muscle cell apoptotic process |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0098552 | Cellular component | side of membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0043236 | Molecular function | laminin binding |
| Gene name | LYPD3 |
| Protein name | Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein) (MIG-C4) LY6/PLAUR domain containing 3 (cDNA PSEC0157 fis, clone PLACE1008238, highly similar to Ly6/PLAUR domain-containing protein 3) (cDNA, FLJ95643, Homo sapiens GPI-anchored metastasis-associated protein homolog(C4.4A), mRNA) |
| Synonyms | hCG_20277 C4.4A UNQ491/PRO1007 |
| Description | FUNCTION: Supports cell migration. May be involved in urothelial cell-matrix interactions. May be involved in tumor progression. . |
| Accessions | O95274 B2RBR3 ENST00000244333.4 |